Hyperbaric oxygen therapy reduces COX-2 expression in a dimethylhydrazine-induced rat model of colorectal carcinogenesis

Undersea and Hyperbaric Medicine

Volumn 39, Issue 3, 2012, Pages 693-698

  Gois, Emanuel ^a   Daniel, Rosemary A F ^a   Parra, Rogerio S ^a   Almeida, Ana L N R ^a   Rocha, José J R ^a   Garcia, Sérgio B ^a   Féres, Omar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CARCINOGEN; CYCLINE; CYCLOOXYGENASE 2; TUMOR PROTEIN;

ABERRANT CRYPT FOCUS; ANIMAL; ANIMAL EUTHANASIA; ARTICLE; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; ENZYMOLOGY; HYPERBARIC OXYGEN; METABOLISM; METHODOLOGY; RANDOMIZATION; RAT; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; ABERRANT CRYPT FOCI; ANIMALS; CARCINOGENS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; EUTHANASIA, ANIMAL; HYPERBARIC OXYGENATION; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84862253153     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gesell LB. Hyperbaric Oxygen Therapy Indications, 12th Ed. The hyperbaric oxygen therapy indications committee report. Durham, NC: Undersea and Hyperbaric Medical Society, 2008.
2. a ed., 2004.
3. Boerema I, Meinjne NG, Brummelkamp WK, Bouma S, Mensch MH, Kamermans F, STERN Hanf M, Aalderen WV. Life without blood: a study of the influence of high atmospheric pressure and hypothermia 6on dilution of blood. J. Cardiov. Surg, n. 1, p. 133-8, 1960.
4. Haapaniemi T, Nylander G, Sirsjo A, Larsson J. Hyperbaric oxygen reduces ischemia-induced skeletal muscle injury. Plast Reconstr Surg. 1996 Mar; 97(3):602-7; discussion 608-9.
5. Yanai A, Hirata Y, Mitsuno Y, Maeda S, Shibata W, Akanuma M, et al. Helicobacter pylori induces antiapoptosis through nuclear factor-kB activation. J Infect Dis. 2003 Dec. 1;188(11):1741-51. Epub 2003 Nov. 25
6. Hammarlund C. The physiologic effects of hyperbaric oxygenation. In: Hyperbaric medicine practice. Kindwall EP, Whelan HT. (ed). Best publishing company. U. S. A. p. 37-68, 2004.
7. D'Agostino Dias M, Fontes B, Poggetti RS, Birolini D. Hyperbaric oxygen therapy: types of injury and number of sessions'a review of 1506 cases. Undersea Hyperb Med. 2008 Jan-Feb; 35(1):53-60.
8. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injures: An evidence based approach. Undersea Hyperb Med, v. 22, n. 1, p. 4-28, 2002.
9. Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med. 2003 Spring; 30(1):1-18.
10. Mayer R, Hamilton-Farrell MR, van der Kleij AJ, Schmutz J, Granstrom G, Sicko Z, et al. Hyperbaric oxygen and radiotherapy. Strahlenther Onkol. 2005 Feb; 181(2):113-23
11. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009 Jan-Feb; 59(1):27-41.
12. Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg. 2006 Dec; 30(12):2112-31.
13. Daruwalla J, Christophi C. The effect of hyperbaric oxygen therapy on tumour growth in a mouse model of colorectal cancer liver metastases. Eur J Cancer. 2006 Dec; 42(18):3304-11. Epub 2006 Sep. 28
14. Freiberger JJ, Yoo DS, de Lisle Dear G, McGraw TA, Blakey GH, Padilla Burgos R, et al. Multimodality surgical and hyperbaric management of mandibular osteoradionecrosis. Int J Radiat Oncol Biol Phys. 2009 Nov. 1;75(3):717-24. Epub 2009 Mar. 26.
15. Macarthur M, Hold GL, El-Omar EM. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004 Apr; 286(4): G515-20.
16. Rodrigues MA, Silva LA, Salvadori DM, De Camargo JL, Montenegro MR. Aberrant crypt loci and colon cancer: comparison between a short-and medium-term bioassay lor colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002 Mar; 35(3):351-5.
17. Kayaselfuk F, Zorludemir S, Gumurduhu D, Zeren H, Erman T. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neurooncol. 2002 Apr; 57(2):115-21.
18. Zeng WJ, Liu GY, Xu J, Zhou XD, Zhang YE, Zhang N. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World J Gastroenterol. 2002 Dec; 8(6):1040-4.
19. Ziliotto L, Barbisan LF, Rodrigues MA. Lack of chemo-prevention of dietary Agaricus blazei against rat colonic aberrant crypt loci. Hum Exp Toxicol. 2008 Jun; 27(6):505-11.
20. Schwartz B, Algamas-Dimantov A, Hertz R, Natal J, Kerman A, Peri I, Bar-Tana J. Inhibition ol colorectal cancer by targeting hepatocyte nuclear lactor-4alpha. Int J Cancer. 2009 Mar. 1;124(5):1081-9.
21. Lee SJ, Lim KT. A 116-kDa phytoglycoprotein inhibits aberrant crypt loci formation through modulation ol manganese superoxide dismutase, inducible nitric oxide synthase, cyclooxygenase-2, nuclear lactor-kappa B, activator protein-1, and prolilerating cell nuclear antigen in 1, 2-dimethylhydrazine/dextran sodium suffate-treated ICR mice. Eur J Cancer Prev. 2008 Nov; 17(6):479-88.
22. Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB. Exercise reduces inflammation and cell prolileration in rat colon carcinogenesis. Med Sci Sports Exerc. 2008 Apr; 40(4):618-21.
23. Williams CS, Mann M, DuBois RN. The role of cyclo-oxygenases in inflammation, cancer, and development. Oncogene. 1999 Dec. 20;18(55):7908-16.
24. Marnett LJ, DuBois RN. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002;42:55-80.
25. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology. 1996 Aug; 111(2):445-54.
26. Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med. 2006 Aug. 31;355(9):885-95.
27. Calonge N, Petitti DB, DeWitt TG, Gordis L, Gregory KD, Harris R, et al. Aspirin for the prevention of cardiovascular disease: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 Mar. 17;150(6):396-404.
28. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007 May 12;369(9573):1603-13.
29. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemo-prevention trial. N Engl J Med. 2005 Mar. 17;352(11):1092-102. Epub 2005 Feb. 15.
30. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006 Aug. 31;355(9):873-84.
31. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005 Mar. 17;352(11):1071-80. Epub 2005 Feb. 15.
32. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer. 2003 Apr; 3(4):276-85.
33. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, et al. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol. 2000 Sep; 157(3):737-45.
34. Ziliotto L, Barbisan LF, Rodrigues MA. Lack of chemo-prevention of dietary Agaricus blazei against rat colonic aberrant crypt foci. Hum Exp Toxicol. 2008 Jun; 27(6):505-11.
35. Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, Pollack S. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol. 1997 Mar; 17(2):154-9.
36. Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB. Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis. Med Sci Sports Exerc. 2008 Apr; 40(4):618-21.